Loring Wolcott & Coolidge Fiduciary Advisors’s Ambev ABEV Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-325	Closed	-$1K	–	746
2021 Q2	$1K	Buy	+325	New	+$1.06K	﹤0.01%	920
2021 Q1	–	Sell	-325	Closed	–	–	301
2020 Q4	$0	Hold	325	–	–	﹤0.01%	764
2020 Q3	$0	Hold	325	–	–	﹤0.01%	585
2020 Q2	$0	Hold	325	–	–	﹤0.01%	582
2020 Q1	$0	Sell	325 -5,875	-95%	-$21.3K	﹤0.01%	645
2019 Q4	$29K	Sell	6,200 -9,000	-59%	-$39.9K	﹤0.01%	481
2019 Q3	$70K	Hold	15,200	–	–	﹤0.01%	378
2019 Q2	$71K	Sell	15,200 -5,750	-27%	-$25.8K	﹤0.01%	365
2019 Q1	$90K	Sell	20,950 -20,645	-50%	-$94.8K	﹤0.01%	332
2018 Q4	$163K	Sell	41,595 -2,045	-5%	-$8.73K	﹤0.01%	269
2018 Q3	$199K	Sell	43,640 -48,018	-52%	-$229K	﹤0.01%	272
2018 Q2	$424K	Sell	91,658 -72,350	-44%	-$425K	0.01%	213
2018 Q1	$1.19M	Sell	164,008 -1,250	-0.8%	-$8.6K	0.02%	153
2017 Q4	$1.07M	Sell	165,258 -1,060	-0.6%	-$6.78K	0.02%	160
2017 Q3	$1.1M	Sell	166,318 -6,475	-4%	-$40.1K	0.02%	154
2017 Q2	$1.05M	Sell	172,793 -2,062	-1%	-$11.8K	0.02%	153
2017 Q1	$1.01M	Sell	174,855 -24,320	-12%	-$133K	0.02%	153
2016 Q4	$978K	Sell	199,175 -16,000	-7%	-$86.4K	0.02%	153
2016 Q3	$1.31M	Sell	215,175 -33,735	-14%	-$202K	0.03%	139
2016 Q2	$1.47M	Sell	248,910 -437,431	-64%	-$2.35M	0.03%	130
2016 Q1	$3.56M	Sell	686,341 -6,085	-0.9%	-$28K	0.08%	100
2015 Q4	$3.09M	Sell	692,426 -96,363	-12%	-$471K	0.08%	107
2015 Q3	$4.81M	Hold	788,789	–	–	0.12%	88
2015 Q2	$4.81M	Sell	788,789 -30,400	-4%	-$188K	0.12%	88
2015 Q1	$4.72M	Sell	819,189 -23,840	-3%	-$148K	0.12%	89
2014 Q4	$5.24M	Sell	843,029 -141,818	-14%	-$896K	0.13%	88
2014 Q3	$6.45M	Sell	984,847 -89,708	-8%	-$632K	0.17%	81
2014 Q2	$7.57M	Sell	1,074,555 -235,975	-18%	-$1.74M	0.2%	74
2014 Q1	$9.71M	Sell	1,310,530 -28,075	-2%	-$197K	0.27%	65
2013 Q4	$9.84M	Buy	+1,338,605	New	+$9.79M	0.27%	63

Other funds holding ABEV

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

SIM

Sprucegrove Investment Management Toronto, Ontario, Canada $639M AUM 23.31% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.83B AUM 30.34% 1-Year Est. Return

WGI

Westwood Global Investments Boston, Massachusetts $2.85B AUM 55.09% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's ABEV Position: Q3 2021 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Ambev (ABEV) in Q3 2021, closing a stake of 325 shares — an estimated $1K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ABEV in Q4 2013 and held it in 30 quarters. The position peaked at $9.84M in Q4 2013. 275 funds tracked by Wall St. Rank hold ABEV as of Q3 2021.

Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Ambev position as of Q3 2021 after selling out during the quarter.
Loring Wolcott & Coolidge Fiduciary Advisors sold 325 Ambev shares in Q3 2021, an estimated $1K.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Ambev in Q4 2013 and held it in 30 quarters.
Loring Wolcott & Coolidge Fiduciary Advisors's Ambev position peaked at $9.84M in Q4 2013.
275 funds tracked by Wall St. Rank held Ambev as of Q3 2021.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.